Overtreatment of multiple myeloma and its precursor states: de-escalation is an urgent need in clinical practice and trials

IF 81.1 1区医学 Q1 ONCOLOGY

Nature Reviews Clinical Oncology Pub Date : 2024-04-22 DOI:10.1038/s41571-024-00895-x

Ghulam Rehman Mohyuddin, Aaron M. Goodman

引用次数: 0

Abstract

Certain subsets of patients with multiple myeloma or its precursor conditions are overtreated with current approaches to therapy. Herein, we highlight several key areas where we believe de-escalation of treatment is needed. Dedicated trials to assess these de-escalation approaches and urgent changes to current clinical practices are needed.

查看原文本刊更多论文

多发性骨髓瘤及其前兆状态的过度治疗：临床实践和试验中亟需降级治疗

多发性骨髓瘤或其前驱疾病患者的某些亚群在目前的治疗方法下治疗过度。在此，我们强调几个我们认为需要降级治疗的关键领域。需要进行专门的试验来评估这些降级治疗方法，并亟需改变目前的临床实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Clinical Oncology 医学-肿瘤学

CiteScore

99.40

自引率

0.40%

发文量

114

审稿时长

6-12 weeks

期刊介绍： Nature Reviews publishes clinical content authored by internationally renowned clinical academics and researchers, catering to readers in the medical sciences at postgraduate levels and beyond. Although targeted at practicing doctors, researchers, and academics within specific specialties, the aim is to ensure accessibility for readers across various medical disciplines. The journal features in-depth Reviews offering authoritative and current information, contextualizing topics within the history and development of a field. Perspectives, News & Views articles, and the Research Highlights section provide topical discussions, opinions, and filtered primary research from diverse medical journals.